País: Reino Unido
Idioma: inglés
Fuente: VMD (Veterinary Medicines Directorate)
Isoflurane
Virbac
QN01AB06
Isoflurane
Inhalation vapour, liquid
POM-V - Prescription Only Medicine – Veterinarian
Cats, Chinchilla, Dogs, Ferrets, Gerbil, Guinea Pig, Hamster, Horses, Mouse, Ornamental Birds, Rat, Reptiles
Neurological Agent general anaesthetic
Authorized
2010-09-16
Revised: February 2016 AN: 01092/2014 Page 1 of 9 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Vetflurane 1000 mg/g Inhalation vapour, liquid 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each millilitre contains: Active substance: Isoflurane 1000 mg/g. The veterinary medicinal product contains no excipients. 3. PHARMACEUTICAL FORM Inhalation vapour, liquid Clear, colourless liquid 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Horses, dogs, cats, ornamental birds, reptiles, rats, mice, hamsters, chinchillas, gerbils, guinea pigs and ferrets. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Induction and maintenance of general anaesthesia. 4.3 CONTRAINDICATIONS Do not use in case of known susceptibility to malignant hyperthermia. Do not use in cases of known hypersensitivity to isoflurane or to other halogenated agents. 4.4 SPECIAL WARNINGS The metabolism of birds, and to an extent small mammals, is affected more profoundly by decreases in body temperature, due to high surface area to body weight ratio. Drug metabolism in reptiles is slow and highly dependent upon environmental temperature. The absorption, distribution and elimination of isoflurane are rapid, and it is eliminated largely unchanged via the lungs. These characteristics may make it suitable for groups of patients including the young or old, or those with impaired hepatic, renal or cardiac function, however anaesthetic protocols should be decided on a case by case basis. Revised: February 2016 AN: 01092/2014 Page 2 of 9 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Isoflurane has little or no analgesic properties. Adequate analgesia should always be given before surgery. The analgesic requirements of the patient should be considered before general anaesthesia is ended. The use of the product in patients with cardiac disease should be considered only after a risk/ benefit assessment by the veterinarian. It’s important to monitor breathing and pulse for the frequency and its features. It’s Leer el documento completo